Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a childhood epilepsy syndrome that becomes more active during sleep
- People whose epilepsy has not been adequately controlled after trying at least two different anti-epileptic medications
- People who have had a sleep brainwave test (EEG) done within the 7 days before joining the trial, which showed abnormal epileptic activity between seizures
Who may not be able to join:
- People who have previously taken a medication called sulthiame
- People who are currently taking more than two anti-epileptic medications at the time of joining
- People who are currently using steroid medications (such as cortisone or prednisone) at the time of joining
- People whose anti-epileptic medication was changed in the 7 days before their sleep brainwave test was done
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Patrick Van Bogaert, Professor, University Hospital, Angers
Phone: 02.41.35.48.46
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of patients showing improved sleep EEG at day 14 compared to baseline EEG
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.